SOLOMON BEN-ASHER, M.D.
The effectiveness of thiouracil in the treatment of the anginal syndrome was first described by Raab1 and Ben-Asher2 in 1945. Clinical improvement was obtained in seven of 10 patients treated by Raab and in eight patients treated by the author. The following year DiPalma and MaGovern3 emphasized the disadvantages of thiouracil in the treatment of angina pectoris. They found, however, that the precordial pain was beneficially affected at least for a period of time in four of their eight patients. In the same year Reveno4 described eight patients with angina pectoris treated with the drug. Improvement was noted in five
Learn more about subscription options.
Register Now for a free account.
BEN-ASHER S. PROPYLTHIOURACIL IN THE TREATMENT OF ANGINA PECTORIS: A COMPARISON WITH THIOURACIL THERAPY(PROPYLTHIOURACIL IN THE TREATMENT OF ANGINA PECTORIS: A COMPARISON WITH THIOURACIL THERAPY*). Ann Intern Med. 1950;32:528–541. doi: 10.7326/0003-4819-32-3-528
Download citation file:
Published: Ann Intern Med. 1950;32(3):528-541.
Cardiology, Coronary Heart Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only